IDO1 and neoplasm: The ubiquitination/deubiquitination process of IDO1 is mediated by the K48-linked ubiquitin chain, and experiments have shown that the USP inhibitor IU1 can effectively inhibit IDO1 deubiquitination and reduce IDO1 levels, thereby reversing tumor immune tolerance and making tumor cells more sensitive to anti-PD-1.81